0732 GMT – IHH Healthcare earnings may continue to improve in the coming quarters, supported by operational strength demonstrated in 3Q, Affin Hwang IB analyst Andrew Lim says in a note. Affin Hwang maintains a buy rating on IHH and keeps its target price at MYR6.70. 2224 GMT – Jefferies raises its price target on Clarity by 21% to A$3.15/share after the radiopharmaceutical company said it would carry out a phase 3 diagnostic trial on advanced prostate cancer patients.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles